Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00894738 · ClinicalTrials.gov registry record
Biomarkers of Cardiometabolic Risk in Children Treated With Antipsychotics: A Preliminary Study of Direct Measures
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 44
- Enrollment target
NCT00894738 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 44 participants.
The verdict
NCT00894738 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The proposed study aims to begin the multi-step process of establishing the reliability and validity of hepatic triglyceride content (HTGC) and carotid artery intima-media thickness (IMT) as biomarkers of cardiometablic risk in children treated for mental illness. The distribution of HTGC and carotid IMT-proximate indicators of cardiometabolic risk-across a range of dual-energy X-ray absorptiometry (DEXA)-measured adiposity in children treated with antipsychotic agents will be characterized in comparison to healthy, untreated, non-psychiatric controls, in order to estimate effect sizes for future studies incorporating these markers. The ability of HTGC and IMT to predict cardiometabolic risk as measured by commonly-used laboratory tests, such as fasting lipids, liver function tests, C-reactive protein and serum fibrinogen, will be assessed.
Interventions
- PROCEDURE Testing (MRS, US, DEXA, blood tests)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2010-01-01 |
| Est. Completion | 2016-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00894738
The ClinicalTrials.gov registry entry for NCT00894738 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testing (MRS, US, DEXA, blood tests) is the first listed.
NCT00894738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00894738 about?
NCT00894738 is a clinical study titled "Biomarkers of Cardiometabolic Risk in Children Treated With Antipsychotics: A Preliminary Study of Direct Measures". The proposed study aims to begin the multi-step process of establishing the reliability and validity of hepatic triglyceride content (HTGC) and carotid artery intima-media thickness (IMT) as biomarkers of cardiometablic risk in children treated for mental illness. The distribution of HTGC and caroti...
What is the current status of trial NCT00894738?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2010-01-01. Estimated completion is 2016-06-01.
What interventions are being tested in trial NCT00894738?
The interventions under investigation include: Testing (MRS, US, DEXA, blood tests) (PROCEDURE).
Who is sponsoring clinical trial NCT00894738?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.